≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_OESOPHAGUS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C15
  • Hospital discharge: ICD-9 — 150
  • Hospital discharge: ICD-8 — 150
  • Cause of death: ICD-10 — C15
  • Cause of death: ICD-9 — 150
  • Cause of death: ICD-8 — 150
  • Cancer registry: Topography ICD-O-3 — C15
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

1314

4. Check minimum number of events

None

1314

5. Include endpoints

None

1314

6. Filter based on genotype QC (FinnGen only)

1314

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1314 297 1017
Unadjusted period prevalence (%) 0.37 0.10 0.45
Median age at first event (years) 68.65 68.93 68.57

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
782
Matched controls
7821
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
506
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
1568.4
323.0
295
*
H02AB02
ATC
dexamethasone; systemic
221.0
323.0
317
24
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
323.0
536
*
A03FA01
ATC
metoclopramide; systemic, rectal
33.8
323.0
483
356
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
303.5
271
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
16.6
259.1
619
1456
A04AA02
ATC
granisetron; systemic, transdermal
1098.6
251.8
233
*
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
249.8
226
*
L01BC06
ATC
capecitabine; oral
+∞
231.0
210
*
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
+∞
219.4
200
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2755.3
210.2
194
*
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
+∞
200.9
184
*
JN4BD
NOMESCO Finland
Extensive body CT
23.9
195.2
292
190
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
188.3
173
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
77.8
185.5
207
36
Z51.5
ICD-10 Finland
Palliative care
35.0
180.0
237
96
N02AA05
ATC
oxycodone; systemic
13.0
179.4
364
492
WX302
NOMESCO Finland
Thoracal epidural anesthesy
55.1
173.1
205
50
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
+∞
156.6
145
*
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
122.5
148.5
157
16
R4190
NOMESCO Finland
Nutritional therapy
57.3
145.4
171
38
WF002
NOMESCO Finland
Radical radiotherapy
1612.4
142.2
134
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
187.3
136.4
139
9
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
134.3
125
*
A04AA01
ATC
ondansetron; systemic, rectal
36.0
127.8
166
58
R13
ICD-10 Finland
Dysphagia
12.7
117.1
225
241
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
115.5
108
*
8140/3-C15.5
ICD-O-3
Adenocarcinoma, NOS, of lower third of esophagus
+∞
114.4
107
*
WX600
NOMESCO Finland
Single shot through catheter
330.4
114.3
113
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
24.1
112.8
164
85
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
+∞
112.2
105
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
398.9
107.0
105
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.2
106.0
198
196
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
+∞
104.6
98
*
C15.1
ICD-10 Finland
Malignant neoplasm: Thoracic part of oesophagus
+∞
99.1
93
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
42.7
98.8
123
34
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
95.8
90
*
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
99.8
95.7
104
12
WF049
NOMESCO Finland
Radiotherapy of metastasis
1000.7
92.8
89
*
UJC12
NOMESCO Finland
Flexible oesophagoscopy
88.7
91.7
101
13
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
16.2
89.9
151
114
JCC10
NOMESCO Finland
Transthoracic partial oesophagectomy without interposition
+∞
88.2
83
*
K22.2
ICD-10 Finland
Oesophageal obstruction
66.4
86.3
99
17
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.1
85.7
347
1052
XX3DW
NOMESCO Finland
Time consuming IT work
12.6
85.3
161
158
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
83.9
79
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
875.3
82.0
79
*
C15.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oesophagus
+∞
81.7
77
*
C15.0
ICD-10 Finland
Malignant neoplasm: Cervical part of oesophagus
+∞
81.7
77
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
72.0
68
*
JN4AD
NOMESCO Finland
Body CT examination
12.3
70.4
133
128
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
66.6
63
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.3
66.4
92
38
JDB10
NOMESCO Finland
Percutaneous gastrostomy
42.2
64.3
80
21
WZC30
NOMESCO Finland
Teaching
6.5
60.4
174
332
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
60.3
262
796
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
74.2
60.3
68
10
A04AD12
ATC
aprepitant; systemic
+∞
57.0
54
*
A02BC02
ATC
pantoprazole; systemic
3.6
56.4
597
3680
WW500
NOMESCO Finland
Blood transfusion
18.0
54.9
87
54
JN4CD
NOMESCO Finland
Very extensive body CT
20.2
54.1
82
45
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.5
54.0
226
652
ZX090
NOMESCO Finland
Other technic of radiotherapy
147.6
52.5
55
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
51.6
49
*
8070/3-C15.5
ICD-O-3
Squamous cell carcinoma, NOS, of lower third of esophagus
+∞
50.6
48
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
49.5
47
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
49.5
47
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
48.4
46
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
48.4
46
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
46.3
44
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
46.3
44
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
474.1
45.7
45
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.6
45.6
145
306
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
45.2
43
*
WX402
NOMESCO Finland
General anaesthesia
4.6
44.3
173
456
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
66.6
43.7
50
8
ZX120
NOMESCO Finland
Intravenous
5.6
42.9
135
280
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
41.7
260
1016
B01AB05
ATC
enoxaparin; parenteral
3.1
41.3
300
1306
L03AA02
ATC
filgrastim; parenteral
151.4
41.2
43
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
32.1
41.0
54
18
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
41.0
39
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
39.9
38
*
UJD02
NOMESCO Finland
Gastroscopy
6.9
38.6
101
164
C16.00
ICD-10 Finland
Cardia
+∞
37.8
36
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
73.7
37.3
42
6
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.6
36.4
64
51
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
99.7
35.0
38
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
34.6
33
*
8070/3-C15.4
ICD-O-3
Squamous cell carcinoma, NOS, of middle third of esophagus
+∞
34.6
33
*
K22.1
ICD-10 Finland
Ulcer of oesophagus
11.0
34.5
67
66
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.2
34.3
97
174
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
34.2
413
2376
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
12.9
34.0
61
51
C15.2
ICD-10 Finland
Malignant neoplasm: Abdominal part of oesophagus
+∞
33.6
32
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
340.7
33.1
33
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
15.5
30.9
51
35
A06AH03
ATC
naloxegol; oral
53.8
30.6
36
7
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
30.4
29
*
A79
ICPC
Malignancy NOS
+∞
30.4
29
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
313.9
30.0
30
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
29.3
28
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
28.3
27
*
1CD01
NOMESCO Finland
NA
+∞
28.3
27
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.8
26.8
124
371
R4110
NOMESCO Finland
Physiotherapy
2.6
26.6
249
1202
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.6
26.6
70
114
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
139.6
25.8
27
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.3
25.5
81
167
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
+∞
25.1
24
*
JDB00
NOMESCO Finland
Gastrostomy
134.3
24.7
26
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
23.6
130
444
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
6.6
23.2
61
99
D84
ICPC
Oesophagus disease
55.8
23.2
27
5
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
31.1
22.9
30
10
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
9.9
22.8
46
49
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
23.8
22.7
32
14
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
123.6
22.7
24
*
WX872
NOMESCO Finland
Intensive care
4.1
22.5
92
245
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
22.1
200
933
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
+∞
22.0
21
*
8000/3-C15.9
ICD-O-3
Neoplasm, malignant of esophagus, NOS
+∞
22.0
21
*
WX002
NOMESCO Finland
Sedation and analgesia
2.5
21.8
198
924
RD210
NOMESCO Finland
NA
10.5
21.6
42
42
A02BC05
ATC
esomeprazole; systemic
2.1
21.5
340
2070
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
34.9
21.2
27
8
116
Kela drug reimbursment
Prostate cancer
+∞
20.9
20
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
20.9
20
*
8140/3-C15.2
ICD-O-3
Adenocarcinoma, NOS, of abdominal esophagus
+∞
20.9
20
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
20.9
20
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
20.9
20
*
K22.7
ICD-10 Finland
Barrett oesophagus
10.2
20.8
41
42
JFF00
NOMESCO Finland
Catheter enterostomy
79.0
20.8
23
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
79.0
20.8
23
*
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
36.8
19.9
25
7
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
19.9
19
*
TJF00
NOMESCO Finland
Insertion of jejunal tube
+∞
19.9
19
*
B01AB10
ATC
tinzaparin; parenteral
5.0
19.6
64
136
J01MA12
ATC
levofloxacin; systemic
2.4
19.2
185
884
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
56.5
19.0
22
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
56.5
19.0
22
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.2
19.0
46
67
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.4
18.9
35
32
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
18.8
18
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
194.4
18.6
19
*
A98
ICPC
Health maint/preventive medicine
0.5
18.3
485
6024
C15
ICD-10 Finland
Malignant neoplasm of oesophagus
+∞
17.8
17
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
17.8
17
*
JCA98
NOMESCO Finland
Other local endoscopic operation on oesophagus
64.8
16.8
19
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
16.7
16
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.7
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.7
16
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
6.0
15.9
44
77
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
15.7
15
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
15.7
15
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
15.7
15
*
1505A
ICD-9 Finland
Malignant neoplasm of oesophagus, Lower third of oesophagus
+∞
15.7
15
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.7
15
*
JAH00
NOMESCO Finland
Laparotomy
6.5
15.0
39
63
A06AD11
ATC
lactulose; oral
2.3
14.8
151
734
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
14.6
14
*
RD160
NOMESCO Finland
NA
36.8
14.5
18
5
K92.0
ICD-10 Finland
Haematemesis
4.6
14.2
49
111
R11
ICD-10 Finland
Nausea and vomiting
3.2
14.0
75
250
SPAT1109
SPAT
Analgesia with portable analgesic pump
54.3
13.8
16
*
8070/3-C15.3
ICD-O-3
Squamous cell carcinoma, NOS, of upper third of esophagus
+∞
13.6
13
*
JCC30
NOMESCO Finland
Transthoracic partial oesophagectomy with interposition of intestine
+∞
13.6
13
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
13.6
13
*
L03
ICPC
Low back symptom/complaint
0.3
13.3
34
985
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
13.1
52
136
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
10.3
13.0
25
25
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
11.8
12.9
23
20
R50.9
ICD-10 Finland
Fever, unspecified
2.4
12.9
111
495
N02AA01
ATC
morphine; systemic, rectal
9.9
12.8
25
26
GBB00
NOMESCO Finland
Tracheostomy
9.9
12.8
25
26
T18.1
ICD-10 Finland
Foreign body in oesophagus
8.0
12.7
28
36
Z43.1
ICD-10 Finland
Attention to gastrostomy
+∞
12.5
12
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
12.5
12
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
12.5
12
*
8144/3-C15.9
ICD-O-3
Adenocarcinoma, intestinal type of esophagus, NOS
+∞
12.5
12
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
12.5
12
*
JFF01
NOMESCO Finland
Laparoscopic catheter enterostomy
+∞
12.5
12
*
D00.1
ICD-10 Finland
Carcinoma in situ: Oesophagus
+∞
12.5
12
*
L02BB03
ATC
bicalutamide; oral
+∞
12.5
12
*
JCF00
NOMESCO Finland
Insertion of prosthetic tube into oesphagus
+∞
12.5
12
*
K22.3
ICD-10 Finland
Perforation of oesophagus
47.4
11.9
14
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
11.5
11
*
L01BC53
ATC
tegafur, combinations; systemic
+∞
11.5
11
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
11.5
11
*
JCB00
NOMESCO Finland
Oesophagostomy
+∞
11.5
11
*
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
+∞
11.5
11
*
GBA35
NOMESCO Finland
Endoscopic insertion of stent into trachea
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
JCA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in oesophagus
121.7
11.5
12
*
JCC00
NOMESCO Finland
Transhiatal partial oesophagectomy without interposition
121.7
11.5
12
*
UGB02
NOMESCO Finland
Tracheoscopy
121.7
11.5
12
*
C10AA07
ATC
rosuvastatin; oral
0.4
11.4
71
1435
JAH01
NOMESCO Finland
Laparoscopy
5.1
11.4
35
71
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
35.6
11.3
14
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
11.1
239
1537
N03AX16
ATC
pregabalin; oral
1.9
11.1
178
1036
R52.0
ICD-10 Finland
Acute pain
5.3
11.0
33
65
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
10.8
91
400
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
18.1
10.8
16
9
N02AX02
ATC
tramadol; systemic, rectal
1.7
10.5
318
2263
Z98.8
ICD-10 Finland
Other specified postsurgical states
7.9
10.4
23
30
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.4
10
*
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
+∞
10.4
10
*
8010/3-C15.9
ICD-O-3
Carcinoma, NOS, of esophagus, NOS
+∞
10.4
10
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
10.4
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.4
10
*
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
+∞
10.4
10
*
8144/3-C15.5
ICD-O-3
Adenocarcinoma, intestinal type of lower third of esophagus
+∞
10.4
10
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
10.4
10
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.0
10.3
21
24
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.3
10.1
94
434
L02AE02
ATC
leuprorelin; implant, parenteral
40.6
10.0
12
*
D21
ICPC
Swallowing problem
6.8
10.0
24
36
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.2
9.9
30
60
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.3
9.9
29
56
B01AB04
ATC
dalteparin; parenteral
3.4
9.8
46
140
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
101.2
9.4
10
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
101.2
9.4
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
101.2
9.4
10
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
9.4
81
1483
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
9.4
9
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
9.4
9
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.2
9.4
20
25
N05BA06
ATC
lorazepam; systemic, sublingual
2.9
9.4
58
213
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.8
9.1
14
9
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
9.0
96
474
N02AA03
ATC
hydromorphone; systemic, rectal
24.3
8.9
12
5
T05
ICPC
Feeding problem of adult
10.9
8.8
16
15
8144/3-C16.0
ICD-O-3
Adenocarcinoma, intestinal type of cardia, NOS
+∞
8.3
8
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
8.3
8
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
8.3
8
*
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
+∞
8.3
8
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.3
8
*
JCC96
NOMESCO Finland
Other partial oesophagectomy
+∞
8.3
8
*
K20
ICD-10 Finland
Oesophagitis
5.6
8.3
23
42
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.2
8.2
42
137
JN6AD
NOMESCO Finland
CT of torso and neck
14.7
8.2
13
9
WX704
NOMESCO Finland
Intubation
2.7
8.2
55
213
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.5
8.1
93
1572
L15
ICPC
Knee symptom/complaint
0.4
8.1
42
914
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.9
8.1
19
28
C10AA05
ATC
atorvastatin; oral
0.6
8.1
187
2651
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
22.3
8.0
11
5
A28
ICPC
Limited function/disability NOS
1.9
8.0
132
770
ZX100
NOMESCO Finland
Oral
7.9
7.9
17
22
J86.9
ICD-10 Finland
Pyothorax without fistula
7.9
7.9
17
22
R4130
NOMESCO Finland
Speech therapy
4.3
7.8
27
64
WX882
NOMESCO Finland
High dependency care
3.6
7.8
33
94
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
45.4
7.7
9
*
N05CF01
ATC
zopiclone; oral
1.6
7.6
246
1744
KA1FN
NOMESCO Finland
Isotope renography
18.6
7.6
11
6
NK6AN
NOMESCO Finland
Total body bone isotope imaging
25.3
7.6
10
*
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
25.3
7.6
10
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.7
7.6
24
52
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
7.5
143
875
M25.5
ICD-10 Finland
Pain in joint
0.5
7.5
61
1143
HAC20
NOMESCO Finland
Total mastectomy
80.8
7.4
8
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
80.8
7.4
8
*
GBB13
NOMESCO Finland
Revision of tracheostomy
80.8
7.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
1504A
ICD-9 Finland
Malignant neoplasm of oesophagus, Middle third of oesophagus
+∞
7.3
7
*
1CD02
NOMESCO Finland
NA
+∞
7.3
7
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
7.3
7
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
7.3
7
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
7.3
7
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
I50.1
ICD-10 Finland
Left ventricular failure
0.2
7.2
6
320
K22.0
ICD-10 Finland
Achalasia of cardia
20.2
7.1
10
5
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
6.7
7.1
17
26
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
6.9
57
248
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
4.9
6.9
21
44
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.5
6.7
62
1116
ZXB10
NOMESCO Finland
Medial
22.7
6.7
9
*
L17
ICPC
Foot/toe symptom/complaint
0.5
6.6
68
1188
N06DX01
ATC
memantine; oral
0.2
6.6
9
360
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
6.9
6.5
15
22
R01AD09
ATC
mometasone; nasal
0.6
6.5
131
1931
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
70.4
6.4
7
*
L02BG04
ATC
letrozole; oral
70.4
6.4
7
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
6.4
51
966
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.5
6.4
14
19
G47.3
ICD-10 Finland
Sleep apnoea
0.5
6.4
67
1164
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.2
6.3
31
100
I50.0
ICD-10 Finland
Congestive heart failure
0.3
6.3
18
499
GAA31
NOMESCO Finland
Thoracoscopy
18.2
6.3
9
5
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.6
6.3
103
1593
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
8480/3-C15.5
ICD-O-3
Mucinous adenocarcinoma of lower third of esophagus
+∞
6.3
6
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
6.3
6
*
8246/3-C15.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of esophagus, NOS
+∞
6.3
6
*
L01CB01
ATC
etoposide; systemic
+∞
6.3
6
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
8070/3-C15.0
ICD-O-3
Squamous cell carcinoma, NOS, of cervical esophagus
+∞
6.3
6
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.2
6.3
31
101
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
6.2
82
440
GDC00
NOMESCO Finland
Lobectomy of lung
26.9
6.2
8
*
UJC02
NOMESCO Finland
Rigid oesophagoscopy
7.1
6.2
14
20
J94.8
ICD-10 Finland
Other specified pleural conditions
5.1
6.2
18
36
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.8
6.2
16
28
UJC01
NOMESCO Finland
Scopy of lower throat
8.7
6.1
12
14
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.9
6.0
23
61

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
730
1292
11.46
307.65
2.3
1.2
—
—
—
0
0
(4035726)
365
282
17.54
307.65
1.5
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
665
530
24.38
307.65
4.9
1.4
ug/l
40.2
4.6
2.44
608
397
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
239
116
24.96
307.65
4.5
1.9
u/ml
391.8
108.2
0.63
223
107
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
325
200
21.26
307.65
4.1
1.8
u/ml
704.2
39.5
1.02
305
160
(3012095) Magnesium [Moles/volume] in Serum or Plasma
603
1475
6.71
254.24
5.3
2.8
mmol/l
0.8
0.8
18.42
591
1363
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
404
766
7.17
217.33
2.9
2.0
g/l
0.2
0.2
0.11
390
687
(3003458) Phosphate [Moles/volume] in Serum or Plasma
495
1339
5.33
177.84
5.4
5.5
mmol/l
0.9
1.0
9.83
483
1230
(3024561) Albumin [Mass/volume] in Serum or Plasma
888
4157
4.50
148.66
9.8
3.9
g/l
31.8
35.2
49.79
872
3820
(3002256) Pathology report gross observation
313
690
5.64
139.38
1.5
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
683
2754
4.08
138.84
5.0
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
574
2157
3.95
126.95
4.2
2.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
921
4812
4.06
122.59
14.2
4.0
umol/l
10.4
12.9
10.59
912
4508
(3023368) Bacteria identified in Blood by Culture
667
2944
3.57
112.41
5.6
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
838
4448
3.44
101.28
8.9
11.1
inr
1.2
1.4
6.88
181
1246
(3020779) Urea [Moles/volume] in Serum or Plasma
327
975
4.13
97.50
4.3
6.8
mmol/l
7.0
10.9
20.71
313
921
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
87
0
+∞
91.75
1.0
0.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
637
3002
3.18
91.58
6.5
2.1
mmol/l
2.3
2.3
1.46
596
2467
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
789
4203
3.20
91.47
6.0
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
603
2761
3.19
91.01
3.2
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
883
5148
3.18
84.90
15.2
6.2
e9/l
4.4
4.5
0.45
794
4416
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
167
344
5.42
78.19
2.2
2.8
u/ml
0.3
0.3
2.11
75
195
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
415
1737
3.03
70.07
6.5
2.1
mmol/l
2.5
2.4
17.09
391
1476
(40758558) Short blood count panel - Blood
455
2145
2.72
59.95
10.6
4.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
260
934
3.22
55.96
17.7
6.7
mmol/l
1.3
1.5
2.53
251
900
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
730
4464
2.43
53.57
12.0
5.5
mmol/l
1.2
1.2
5.96
697
3946
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
316
1298
2.89
53.49
17.7
7.3
kpa
5.3
5.1
2.88
310
1238
(3027801) Oxygen [Partial pressure] in Arterial blood
316
1298
2.89
53.49
17.6
7.3
kpa
11.8
11.4
0.83
309
1237
(3003396) Base excess in Arterial blood by calculation
315
1293
2.89
53.38
17.5
7.3
mmol/l
1.2
1.2
0.11
282
991
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
775
4884
2.43
52.89
12.9
5.9
mmol/l
1.2
1.2
4.25
671
4100
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
209
684
3.44
52.12
1.6
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
538
2922
2.42
50.91
3.9
2.7
u/l
33.5
44.8
1.07
527
2760
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
188
587
3.57
50.35
18.3
10.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
243
902
3.08
49.01
19.6
7.8
—
—
—
0
0
(3000492) Spirometry study
228
835
3.09
46.95
1.4
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
883
6078
2.38
46.65
11.3
4.7
mmol/l
6.7
6.9
2.71
869
5700
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
530
3098
2.19
39.78
3.1
2.3
u/l
56.7
59.1
0.49
508
2837
(3018677) aPTT in Platelet poor plasma by Coagulation assay
340
1667
2.40
38.71
1.7
1.9
s
30.2
30.1
0.11
333
1611
(3018418) pH of Serum or Plasma
487
2808
2.17
37.31
4.9
3.4
ph
7.4
7.4
0.41
99
492
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
985
7442
2.29
36.88
15.3
5.4
u/l
94.8
77.6
12.92
966
6869
(3003694) ABO and Rh group [Type] in Blood
429
2367
2.21
36.61
1.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
319
1581
2.34
35.03
2.3
2.5
umol/l
9.6
12.9
12.25
310
1442
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
817
10193
0.48
34.89
4.1
5.4
mmol/l
2.6
2.6
0.54
726
9295
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
783
9866
0.49
33.12
3.7
4.8
mmol/l
1.4
1.4
1.60
692
8978
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
756
9622
0.50
32.56
5.8
6.6
mmol/mol
41.0
41.1
0.04
681
8849
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
196
799
2.71
32.47
2.6
2.2
u/l
388.6
41.5
0.48
169
662
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
796
9957
0.49
32.46
3.7
4.8
mmol/l
4.4
4.4
0.16
720
9126
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
220
969
2.53
31.06
2.6
2.5
umol/l
10.2
9.6
0.12
202
846
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
23
11
21.26
30.35
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
133
457
3.13
30.04
2.1
1.7
ug/l
1.2
2.0
1.09
124
396
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
275
1363
2.29
29.70
2.1
2.6
%
17.3
23.4
8.17
242
1145
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
429
2536
2.03
29.33
2.2
2.2
mg/l
3.6
2.9
3.80
384
2115
(3004789) Transferrin [Mass/volume] in Serum or Plasma
285
1447
2.24
28.97
2.1
2.5
g/l
2.3
2.2
1.00
271
1326
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
162
639
2.75
28.46
1.5
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
496
3145
1.93
27.24
4.4
5.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
320
1738
2.11
27.24
1.8
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
55
109
5.22
26.54
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
49
88
5.75
26.29
1.6
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
631
4398
1.84
25.19
4.8
5.7
%
20.9
26.3
25.31
603
4039
(3006504) Eosinophils/100 leukocytes in Blood
620
4313
1.83
24.78
4.7
5.6
%
2.4
3.0
9.42
597
3966
(3019069) Monocytes/100 leukocytes in Blood
621
4326
1.83
24.67
4.8
5.8
%
9.3
9.0
0.89
596
4000
(3042936) Bacteria identified in Isolate by Culture
272
1446
2.11
24.20
2.3
2.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
602
4186
1.81
23.79
4.7
5.6
%
0.6
0.7
1.63
579
3856
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
783
9563
0.55
23.14
3.6
4.3
mmol/l
1.3
1.3
0.11
697
8632
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
238
1241
2.12
22.11
1.8
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
431
2763
1.83
21.83
3.0
3.0
e6/l
1.0
0.5
0.61
332
2088
(3002582) Erythrocytes [#/volume] in Urine
462
3027
1.81
21.77
3.1
3.0
e6/l
36.7
83.2
1.29
361
2337
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
237
1243
2.11
21.65
1.8
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
608
4362
1.73
20.61
4.8
5.5
%
62.7
58.3
12.14
585
4037
(3019198) Lymphocytes [#/volume] in Blood
646
4719
1.73
20.46
4.8
5.4
e9/l
1.7
1.8
1.81
547
4091
(36304419) Bacteria [Presence] in Urine
412
2662
1.80
20.00
2.9
2.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
206
1070
2.10
19.15
2.8
2.7
u/l
228.5
237.0
0.48
196
996
(3006315) Basophils [#/volume] in Blood
633
4654
1.69
19.13
4.6
5.3
e9/l
0.0
0.0
0.04
529
3976
(3001604) Monocytes [#/volume] in Blood
629
4623
1.69
18.99
4.5
5.3
e9/l
0.7
0.6
4.62
525
3944
(3013115) Eosinophils [#/volume] in Blood
645
4810
1.67
18.13
4.9
5.4
e9/l
0.2
0.2
5.92
546
4166
(3023199) Leukocytes [#/volume] in Pleural fluid
47
116
4.16
17.41
1.4
1.5
e6/l
1536.5
1871.0
0.29
32
83
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
268
1574
1.88
17.40
2.9
2.9
e6/l
2.2
1.5
0.73
153
875
(1761868) Lipid panel - Serum or Plasma
182
3217
0.50
17.21
2.8
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
41
94
4.47
16.69
1.4
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
44
108
4.18
16.42
1.7
3.0
%
2.0
1.6
0.22
38
78
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
138
656
2.23
15.96
1.9
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
43
106
4.16
15.96
1.4
1.5
e6/l
53947.5
97414.7
0.26
26
66
(3026782) Osmolality of Urine
308
1936
1.77
15.87
2.6
2.6
mosm/kgh2o
517.9
562.4
3.10
277
1620
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
341
4919
0.59
15.69
3.6
3.7
%
20.9
24.1
4.01
156
2357
(3018095) Leukocytes [#/volume] in Urine
483
3457
1.63
15.18
3.5
3.4
e6/l
66.5
101.0
1.00
371
2499
(3012441) Differential panel - Pleural fluid
41
102
4.12
15.04
1.3
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
22
8.75
15.03
1.3
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
462
6104
0.63
14.24
4.0
3.8
ug/l
2.3
2.0
1.44
400
5466
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
494
3632
1.58
13.48
3.0
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
203
1186
1.84
13.14
1.8
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
490
3633
1.56
12.70
3.0
2.8
ug/l
158.4
166.5
0.21
453
3288
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
267
1712
1.70
12.50
2.7
2.7
e6/l
1.8
1.0
1.54
148
1007
(3000850) Epithelial cells [#/volume] in Urine
309
2100
1.62
11.43
2.3
2.3
e6/l
6.3
4.0
1.50
280
1828
(3020630) Protein [Mass/volume] in Serum or Plasma
156
887
1.86
10.94
1.9
1.6
g/l
59.7
66.8
13.92
148
799
(3002032) Base excess in Venous blood by calculation
180
1070
1.79
10.92
3.3
3.4
mmol/l
3.0
2.0
2.06
143
854
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
68
282
2.49
10.73
1.5
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
103
514
2.09
10.51
3.3
3.8
mmol/l
24.7
24.3
0.46
98
447
(3021447) Carbon dioxide [Partial pressure] in Venous blood
178
1072
1.76
10.31
3.3
3.3
kpa
5.8
5.8
0.35
172
1029
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
762
8796
0.68
10.11
4.2
4.1
mu/l
2.0
2.2
0.49
683
7833
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
146
838
1.84
9.92
4.9
2.4
ml/min/173m2
75.1
62.5
2.48
64
329
(3020891) Body temperature
98
492
2.07
9.85
5.8
4.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
579
7008
0.69
9.77
3.7
3.3
pmol/l
15.1
15.0
0.26
528
6213
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
52
198
2.69
9.77
1.6
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
888
9927
0.67
9.56
4.5
5.0
mmol/l
6.1
6.2
0.58
829
8928
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
37
5.20
9.37
2.8
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
262
3664
0.64
9.09
3.0
3.3
mg/l
296.5
173.1
0.22
181
2420
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
309
2201
1.53
9.07
3.6
4.0
ng/l
152.6
522.9
4.20
275
1883
(3020682) Albumin/Creatinine [Ratio] in Urine
281
3868
0.65
9.03
3.7
4.1
mg/mmol
10.3
8.3
0.32
181
2558
(3012501) Base excess in Blood by calculation
57
237
2.47
8.98
5.1
4.6
mmol/l
3.3
2.8
0.51
41
158
(3028707) Methadone [Presence] in Urine by Screen method
22
52
4.29
8.68
1.5
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
21
49
4.34
8.42
6.2
3.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
246
3428
0.65
8.22
2.8
2.7
ug/l
0.7
0.7
0.22
173
2317
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
20
46
4.40
8.16
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
353
2639
1.46
8.05
1.7
1.5
nmol/l
19.9
20.0
0.03
333
2213
(3031040) Bacteria [#/volume] in Urine by Automated count
737
6278
1.40
7.97
3.9
4.2
e6/l
147.9
1803.6
1.56
12
102
(3010421) pH of Blood
62
284
2.24
7.89
5.0
4.3
ph
7.4
7.4
0.08
54
231
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
54
236
2.34
7.67
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
54
236
2.34
7.67
1.2
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
12
9
13.44
7.39
1.4
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
280
3728
0.68
7.23
2.8
3.2
mmol/l
7.4
8.0
1.63
231
3103
(40768441) Liver Pathology biopsy report
16
34
4.75
7.17
1.1
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
70
351
2.05
7.11
2.1
2.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
194
1317
1.55
6.96
1.8
2.0
%
1.8
1.8
0.13
174
1154
(3026008) Bacteria identified in Urine by Culture
350
2679
1.42
6.87
2.7
3.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
142
898
1.65
6.84
3.0
2.7
kpa
4.4
4.4
0.14
137
857
(4198724)
11
17
6.52
6.78
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
129
798
1.68
6.75
8.3
5.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
150
2.58
6.73
2.9
3.0
%
64.8
58.9
1.95
38
150
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
30
105
2.90
6.66
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
20
55
3.68
6.49
1.1
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
506
4149
1.36
6.46
13.7
8.8
e9/l
0.0
0.0
0.65
393
3377
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
60
295
2.08
6.45
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
85
1431
0.57
6.11
1.1
1.3
iu/ml
40.6
37.3
0.11
26
422
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
200
2763
0.67
6.10
1.8
1.6
mmol/l
1.3
1.4
0.67
177
2267
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
123
774
1.65
6.04
5.8
3.1
mmol/l
1.2
1.2
0.37
117
655
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
81
1376
0.56
6.01
1.1
1.2
u/ml
58.9
12.7
0.43
30
508
(3000570) Elastase.pancreatic [Mass/mass] in Stool
53
258
2.10
5.87
1.4
1.5
ug/g
270.9
281.2
0.15
43
157
(3042631) Mycobacterium sp identified in Specimen
32
125
2.60
5.82
2.2
2.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
21
65
3.27
5.74
1.0
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
55
276
2.04
5.63
4.4
3.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
35
146
2.44
5.57
2.5
2.9
e9/l
5.2
4.6
0.59
35
146
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
416
0.26
5.52
2.2
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
20
62
3.26
5.46
1.6
2.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
30
4.37
5.30
1.5
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
21
69
3.08
5.23
1.3
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
23
81
2.87
5.10
6.0
3.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
31
4.23
5.09
1.7
2.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
113
728
1.60
5.08
2.3
3.9
%
1.5
0.8
2.27
57
169
(3021879) Hepatitis B virus core Ab [Presence] in Serum
75
435
1.77
4.99
1.2
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
72
418
1.76
4.79
1.9
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
22
79
2.82
4.73
1.7
3.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
47
240
1.99
4.64
3.0
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
221
1663
1.40
4.63
20.2
28.8
inr
1.3
1.4
0.70
33
228
(3010813) Leukocytes [#/volume] in Blood
1030
10904
0.74
4.48
48.7
20.2
e9/l
7.4
6.8
11.39
997
10479
(3000963) Hemoglobin [Mass/volume] in Blood
1030
10903
0.74
4.46
48.9
20.3
g/l
119.8
138.1
183.07
1018
10660
(3026361) Erythrocytes [#/volume] in Blood
1030
10902
0.74
4.45
48.6
20.2
e12/l
4.1
4.5
104.20
999
10473
(3024731) MCV [Entitic volume]
1030
10901
0.74
4.43
48.4
20.1
fl
91.5
91.6
0.37
1020
10659
(3035941) MCH [Entitic mass]
1030
10900
0.75
4.42
48.4
20.1
pg
30.1
30.6
11.23
1020
10659
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
24
94
2.58
4.40
1.4
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1030
10898
0.75
4.39
48.6
20.2
e9/l
263.4
235.4
23.52
1005
10516
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
30
630
0.46
4.36
2.1
1.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
116
781
1.53
4.33
3.4
1.7
nmol/l
430.4
363.5
2.81
110
701
(3025468) Yersinia sp identified in Specimen by Organism specific culture
24
95
2.55
4.31
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
24
95
2.55
4.31
1.4
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
37
178
2.11
4.30
1.2
1.3
mmol/l
56.2
63.6
0.60
29
145
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
78
2.72
4.26
1.7
3.1
%
67.6
56.9
1.20
16
50
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
521
4483
1.27
4.18
2.2
2.0
pmol/l
85.6
92.3
2.83
328
2410
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
65
382
1.74
4.18
1.8
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
148
2.19
4.11
1.2
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
206
1.97
3.90
1.3
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
29
132
2.22
3.88
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
139
1000
1.44
3.76
4.4
3.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
96
2.42
3.74
1.4
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
159
1177
1.40
3.67
1.9
2.4
ug/l
4.3
8.0
5.64
131
1030
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
31
149
2.11
3.65
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
23
98
2.37
3.58
1.4
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
19
74
2.59
3.56
1.5
1.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
32
610
0.51
3.55
1.9
2.5
—
17.1
—
0
18
(21494755) Public health laboratory ask at order entry panel
28
555
0.49
3.50
1.2
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
45
251
1.82
3.49
2.3
2.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
30
146
2.08
3.43
2.3
2.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
15
53
2.85
3.36
1.1
1.2
nmol/l
117.4
143.1
1.16
15
53
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
169
1.98
3.31
1.4
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
28
543
0.51
3.30
1.1
1.3
—
54.9
—
0
27
(3021440) Promyelocytes/100 leukocytes in Blood
100
697
1.47
3.22
2.4
3.9
%
0.1
0.1
0.18
46
154
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
39
214
1.85
3.20
1.2
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
110
2.20
3.20
1.5
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
137
2.07
3.18
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
98
2.27
3.14
1.4
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
24
112
2.16
3.07
1.5
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
270
2220
1.27
3.02
1.9
1.8
nmol/l
1193.4
1146.0
0.34
217
1669
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
12
5.86
3.02
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
24
113
2.14
3.01
1.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
24
114
2.13
2.95
1.6
1.3
—
—
—
0
0
(1002224) Polysomnography panel
14
333
0.41
2.90
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
26
129
2.04
2.87
1.2
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
139
1051
1.36
2.85
5.9
3.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
124
924
1.38
2.79
1.3
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
23
3.93
2.77
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
93
662
1.44
2.72
2.4
4.0
%
0.0
0.7
0.55
43
131
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
18
377
0.47
2.70
1.8
1.8
nmol/l
47.7
41.0
0.25
18
357
(3026493) Urate [Moles/volume] in Serum or Plasma
241
2894
0.80
2.65
2.6
2.6
umol/l
4458.1
7091.1
0.40
202
2469
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
49
2.67
2.62
1.6
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
49
2.67
2.62
1.5
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
69
0.00
2.60
0.0
1.1
—
7.9
—
0
16
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
100
2.12
2.59
1.3
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
21
102
2.08
2.48
1.7
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
226
1.70
2.45
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
207
0.38
2.42
1.0
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
56
369
1.54
2.41
12.7
7.0
mmol/l
1.3
1.3
0.03
48
328
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
73
1026
0.69
2.40
1.3
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
19
90
2.13
2.39
2.1
2.1
%
8.8
11.1
1.51
19
90
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
371
0.50
2.36
1.3
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
72
505
1.45
2.31
1.2
1.6
g/l
1.6
1.5
0.46
63
430
(3027944) Amphetamines [Presence] in Urine
22
112
1.98
2.31
1.6
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
103
1356
0.74
2.29
3.8
5.0
%
31.4
32.3
0.44
71
882
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
101
754
1.37
2.28
1.3
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
34
201
1.71
2.26
1.4
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
18
3.90
2.25
1.4
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
15
66
2.29
2.25
8.9
2.1
ph
7.4
7.4
—
10
26
(3005322) IgE [Units/volume] in Serum or Plasma
29
491
0.58
2.24
1.2
1.3
u/ml
270.8
274.0
0.01
23
454
(3000494) Fungus identified in Specimen by Culture
147
1164
1.30
2.23
1.5
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
240
2019
1.23
2.19
1.7
1.6
mg/l
2.0
1.3
2.14
199
1568
(3039443) Prostate specific Ag panel - Serum or Plasma
16
320
0.49
2.15
1.4
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
65
913
0.70
2.15
2.1
2.2
ug/g
269.4
178.8
0.69
54
726
(3033705) Calcium.ionized [Moles/volume] in Venous blood
26
144
1.82
2.15
2.5
2.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
68
2.22
2.11
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1012
10531
0.83
2.11
18.7
9.3
u/l
25.2
27.6
1.52
993
10041
(4094501)
16
315
0.50
2.07
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
275
0.47
2.06
1.2
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
89
663
1.37
2.06
2.4
3.8
%
1.3
0.5
1.85
35
122
(3027273) Bicarbonate [Moles/volume] in Venous blood
81
595
1.39
2.04
3.1
2.9
mmol/l
25.6
25.1
0.85
76
572
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
111
1.91
2.01
5.0
4.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
44
2.51
2.01
1.1
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
91
1.99
1.95
1.6
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
119
937
1.30
1.91
1.3
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1018
9762
1.19
1.90
36.1
13.9
mg/l
41.1
26.1
34.00
983
7689
(3037467) Urinalysis macro (dipstick) panel - Urine
717
6692
1.16
1.89
3.6
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
225
1913
1.21
1.85
3.8
4.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
59
2.22
1.84
1.5
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
20
108
1.87
1.82
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
86
1117
0.75
1.78
1.1
1.3
titre
546.1
471.0
0.12
23
249
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
336
0.56
1.77
1.3
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
125
1002
1.27
1.76
1.8
2.2
e9/l
74.4
68.4
0.58
90
780
(40768793) Breast Pathology biopsy report
10
41
2.45
1.75
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
478
4353
1.15
1.73
3.8
4.0
ng/l
33.1
69.0
2.08
396
3319
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
48
0.00
1.70
0.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
19
3.17
1.66
1.2
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
31
2.59
1.66
1.3
2.5
—
6647.8
—
0
5
(4034850)
24
389
0.61
1.63
12.2
10.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
91
1.88
1.61
1.1
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
84
1.92
1.60
1.1
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
330
3681
0.86
1.56
3.4
3.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
70
914
0.75
1.53
2.0
2.2
nmol/l
11.7
14.9
1.59
56
789
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
44
2.28
1.53
3.4
3.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
143
0.42
1.52
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
121
1473
0.80
1.51
13.9
7.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
651
6095
1.13
1.51
3.3
3.0
u/l
80.3
54.5
3.97
618
5563
(3017569) Oxygen content in Arterial blood
14
72
1.95
1.49
8.2
1.6
—
—
—
0
0
(44806118)
19
109
1.75
1.47
1.1
1.4
—
—
—
0
0
(44790047)
19
109
1.75
1.47
1.1
1.4
—
—
—
0
0
(44790049)
19
109
1.75
1.47
1.1
1.4
—
—
—
0
0
(44790048)
19
109
1.75
1.47
1.1
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
74
1.90
1.39
1.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
74
1.90
1.39
1.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
74
1.90
1.39
1.1
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
75
1.88
1.34
1.4
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
38
0.00
1.34
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
39
0.00
1.34
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
61
1.98
1.33
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
443
4797
0.88
1.32
3.1
3.5
estimate
0.0
0.0
0.00
88
783
(40761511) CBC panel - Blood by Automated count
984
10160
0.87
1.31
30.5
13.6
—
—
—
0
0
(3044889) 12 lead EKG panel
764
7263
1.12
1.31
5.2
4.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
24
2.51
1.30
1.2
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
77
607
1.29
1.29
3.3
3.2
e9/l
4.9
4.2
0.77
61
429
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
304
0.62
1.27
1.3
1.3
—
—
—
0
0
(4281824)
8
35
2.29
1.27
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
91
735
1.26
1.26
1.3
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
119
0.42
1.24
1.0
1.1
g/l
1.6
1.5
—
5
101
(3025941) Bacteria identified in Stool by Culture
60
460
1.32
1.24
1.3
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1022
10515
0.87
1.24
42.7
17.2
mmol/l
3.9
4.0
15.34
1010
10188
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
131
1.61
1.24
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
51
671
0.75
1.22
1.9
2.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
49
2.05
1.22
1.1
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
49
2.05
1.22
1.1
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
438
4727
0.89
1.22
4.3
4.6
estimate
0.0
0.0
0.00
93
823
(4146454)
7
143
0.49
1.21
2.3
2.5
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
71
1.84
1.19
1.5
1.5
—
77.8
—
0
5
(3009445) Proteinase 3 Ab [Units/volume] in Serum
33
463
0.71
1.18
1.0
1.6
—
41.3
—
0
11
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
31
2.26
1.10
1.1
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
207
0.58
1.10
1.8
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
13
74
1.76
1.07
1.2
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
145
1.53
1.06
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
241
0.62
1.05
1.6
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.1
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.1
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.1
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
22
2.28
1.03
4.2
2.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
20
299
0.66
1.03
1.6
1.6
e6/l
6737.1
13781.6
0.99
14
219
(3019550) Sodium [Moles/volume] in Serum or Plasma
1022
10482
0.89
1.03
42.4
17.1
mmol/l
138.4
139.8
43.38
1011
10170
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
247
1.39
1.02
1.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
199
2232
0.87
1.02
3.3
3.8
kg/l
1.0
1.0
0.01
28
344
(3035350) Ketones [Presence] in Urine by Test strip
444
4745
0.90
1.00
3.1
3.5
estimate
0.0
0.0
0.00
89
813
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
401
0.72
0.99
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
66
531
1.26
0.99
2.4
2.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
49
1.84
0.98
1.1
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
314
3416
0.89
0.98
1.9
2.2
u/l
444.6
252.9
0.45
303
3177
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
36
1.95
0.97
1.1
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
36
1.95
0.97
1.1
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
124
1.54
0.97
1.8
2.5
mg/l
34.8
20.2
—
6
28
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
50
1.81
0.96
1.1
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
16
246
0.65
0.95
1.0
1.2
mg/l
527.9
523.7
0.02
16
229
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
37
487
0.75
0.93
1.4
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
27
2.23
0.93
3.0
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
184
0.59
0.93
1.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
29
209
1.40
0.93
1.3
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
201
1.40
0.92
1.3
1.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
28
2.15
0.91
1.7
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
220
2430
0.89
0.90
3.1
3.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
205
0.63
0.87
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
136
1.48
0.87
1.9
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
39
301
1.30
0.83
1.4
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
28
376
0.74
0.83
1.4
1.6
—
409.5
—
0
19
(3006184) Hemoglobin [Mass/volume] in Capillary blood
33
249
1.33
0.82
2.8
2.1
g/l
123.3
132.8
1.28
24
188
(3036071) Salmonella sp Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
66
1.67
0.78
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
197
0.66
0.75
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
323
0.74
0.74
1.5
1.4
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
55
1.64
0.73
1.7
1.3
u/l
187.9
390.5
—
9
50
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
176
1.37
0.73
1.3
1.4
u/l
10.5
6.2
1.38
19
147
(40767503) Oxygen content in Capillary blood by calculation
31
237
1.32
0.73
2.7
2.3
%
13.5
16.4
2.58
18
126
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
60
1.67
0.72
1.0
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
388
3654
1.09
0.71
2.2
2.1
nmol/l
71.9
76.5
2.52
358
3162
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
182
0.66
0.71
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
27
1.85
0.68
2.0
2.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
179
0.67
0.66
1.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
246
2651
0.91
0.65
3.2
3.7
estimate
0.0
0.0
0.50
77
773
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
458
4808
0.93
0.65
2.4
2.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
104
0.58
0.62
1.8
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
704
7266
0.93
0.61
3.3
4.0
mm/h
18.6
12.5
13.13
639
6627
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
8
50
1.60
0.61
1.6
1.4
u/field
0.9
3.3
—
8
36
(3045424) Erythrocytes [Presence] in Urine
9
138
0.65
0.60
2.2
1.4
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
22
0.00
0.59
0.0
3.1
—
55.9
—
0
6
(3021901) Oxygen saturation in Capillary blood
28
219
1.28
0.59
2.8
2.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
38
309
1.24
0.58
3.2
2.9
mmol/l
26.6
25.0
0.96
32
273
(3048879) Bone marrow aspiration report
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
36
1.67
0.56
1.2
2.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
16
218
0.73
0.56
1.1
1.3
e6/l
8.3
1085.5
—
10
180
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
218
0.73
0.56
1.1
1.3
e6/l
21.4
46.6
—
10
175
(4062490)
5
88
0.57
0.56
1.0
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
89
0.56
0.56
1.0
1.2
g/l
0.3
0.4
—
5
64
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
89
0.56
0.56
1.0
1.2
g/l
5.9
7.0
—
5
65
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
89
0.56
0.56
1.0
1.2
g/l
3.4
2.9
—
5
65
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
154
1683
0.90
0.56
1.2
1.2
u/ml
3.0
1.7
0.38
35
455
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
90
0.55
0.55
1.0
1.1
—
—
—
0
0
(4015189)
6
37
1.62
0.55
1.5
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
260
0.77
0.53
1.9
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
32
259
1.24
0.52
3.0
3.1
nmol/l
1.0
0.8
0.45
25
204
(40761536) Microorganisms panel - Urine sediment
86
762
1.14
0.52
3.1
3.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
63
1.43
0.52
2.4
2.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
20
259
0.77
0.51
1.2
1.4
g/l
1.2
1.2
0.16
20
245
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
22
281
0.78
0.51
1.0
1.2
—
8.0
—
0
8
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
45
1.56
0.49
23.7
12.4
nmol/l
1292.0
1306.2
—
7
45
(3009542) Hematocrit [Volume Fraction] of Blood
881
8630
1.06
0.48
38.6
15.5
%
35.6
40.1
37.64
618
5536
(40768443) Skin Pathology biopsy report
29
354
0.82
0.47
1.3
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
49
1.43
0.46
1.1
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
83
0.60
0.45
1.0
1.0
—
—
—
0
0
(4268621)
5
84
0.59
0.45
2.0
2.2
—
—
—
0
0
(3009343) pH of Capillary blood
80
714
1.13
0.45
2.8
3.3
ph
7.4
7.4
0.06
12
89
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
116
1058
1.11
0.45
1.8
1.8
%
1.8
1.6
0.76
93
897
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
121
0.66
0.45
1.0
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
803
7858
1.06
0.43
43.4
16.8
%
15.0
13.7
59.57
790
7623
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
81
727
1.12
0.43
2.9
3.3
kpa
5.4
5.2
0.94
74
668
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
20
251
0.79
0.42
1.2
1.4
g/l
0.2
0.2
0.49
20
240
(3020876) Protein [Mass/time] in 24 hour Urine
6
92
0.65
0.42
1.2
1.8
—
1.3
—
0
8
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
87
1.38
0.42
1.8
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
137
1479
0.92
0.41
1.3
1.3
g/l
3.1
2.8
0.38
74
866
(3009015) Lactate [Moles/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.1
—
7.7
—
0
7
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
4.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
40.6
—
0
16
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
59
1.36
0.41
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
59
1.36
0.41
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
34
287
1.19
0.40
4.3
4.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
76
683
1.12
0.40
2.7
3.3
mmol/l
3.7
1.8
2.73
58
494
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
35
1.43
0.39
4.8
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
35
1.43
0.39
4.8
2.3
—
—
—
0
0
(4133840)
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
19
0.00
0.39
0.0
7.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
114
0.70
0.37
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
115
0.69
0.37
1.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
69
765
0.90
0.36
1.3
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
78
0.64
0.35
1.0
1.1
—
70.3
—
0
7
(3047189) Immunofixation for 24 hour Urine
6
42
1.43
0.35
1.2
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
5
80
0.62
0.35
1.0
2.5
mmol/l
8.6
7.1
—
5
50
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
73
1.37
0.34
1.2
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
189
0.79
0.34
1.2
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
44
1.37
0.34
3.0
2.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
45
1.33
0.33
1.0
2.4
—
55.4
—
0
5
(3022313) Gas panel - Capillary blood
58
520
1.12
0.33
2.9
3.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
17
210
0.81
0.33
1.6
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
199
0.80
0.33
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
85
926
0.91
0.33
2.5
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
46
407
1.13
0.32
3.0
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
56
623
0.89
0.32
1.8
2.0
g/l
10.8
11.0
0.12
51
570
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
47
1.28
0.32
1.7
2.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
26
220
1.19
0.32
1.8
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
29
248
1.17
0.32
1.3
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
400
0.87
0.31
1.9
1.9
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
99
0.71
0.30
1.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
346
0.86
0.30
1.1
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
141
0.78
0.29
1.1
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
62
1.29
0.28
1.5
2.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
62
1.29
0.28
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
55
605
0.91
0.27
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
139
0.79
0.27
1.3
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
367
3563
1.04
0.26
2.6
3.1
ng/l
1482.8
1657.6
0.36
327
3050
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.0
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
59
540
1.10
0.25
3.6
3.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
917
9277
0.96
0.25
35.0
12.9
ml/min/173m2
85.3
75.8
37.50
836
7488
(3044242) Glucose [Moles/volume] in Arterial blood
9
73
1.23
0.25
11.9
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
24
277
0.86
0.25
1.5
1.6
iu/ml
0.0
0.3
—
8
63
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
19
223
0.85
0.24
1.0
1.2
—
556.0
—
0
5
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
39
1.28
0.23
4.2
8.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
40
1.25
0.22
2.0
1.5
e6/l
645.6
374.1
—
5
35
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
41
1.22
0.22
1.2
1.1
—
18.4
—
0
7
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
135
1.19
0.21
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.2
—
7.5
—
0
6
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
2.0
—
0
12
(3044941) Cell count panel - Synovial fluid
17
198
0.86
0.20
1.4
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
246
2384
1.04
0.20
1.7
1.7
pmol/l
434.9
40177129.9
2.60
203
1924
(3044290) Cell count panel - Cerebral spinal fluid
16
187
0.85
0.20
1.1
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
46
499
0.92
0.19
1.4
1.4
g/l
1.2
1.1
0.11
41
458
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
118
1.19
0.19
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
45
415
1.09
0.18
1.1
1.2
iu/ml
122.5
135.9
0.10
15
154
(3004451) EKG impression Narrative
7
58
1.21
0.18
1.6
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
100
1.20
0.18
1.7
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
271
1.11
0.18
1.3
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
351
0.91
0.17
2.1
2.2
ug/min
185.7
101.8
0.63
17
211
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
19
167
1.14
0.17
1.8
1.8
mmol/l
1.8
1.7
0.08
19
161
(3013512) EKG study
328
3208
1.03
0.16
4.4
4.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
273
1.10
0.16
1.3
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
121
1.16
0.15
1.3
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
46
430
1.07
0.14
2.7
3.6
mmol/l
26.0
24.7
1.42
41
394
(21494434) Karyotype in Bone marrow
7
88
0.79
0.14
1.0
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
31
336
0.92
0.14
2.2
2.6
g/l
0.2
0.3
0.86
19
125
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
70
735
0.95
0.13
3.8
4.0
ng/l
104.2
97.8
0.20
63
645
(42529406) Shigella sp [Presence] in Stool by Culture
30
276
1.09
0.13
1.3
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
180
0.89
0.13
1.5
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
13
113
1.15
0.13
1.1
1.2
%
123.2
112.7
0.47
13
103
(3011397) Hemoglobin [Presence] in Urine by Test strip
230
2350
0.97
0.12
2.8
3.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
805
8104
0.98
0.10
44.2
18.5
g/l
327.5
333.3
52.34
799
8026
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
44
1.14
0.10
1.8
2.3
u/ml
9222.0
1117.3
—
5
44
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
63
0.79
0.08
1.0
1.1
—
3.2
—
0
19
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
65
0.77
0.08
1.0
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
67
1.05
0.08
6.6
12.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
73
0.82
0.07
1.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
74
0.81
0.07
1.7
1.4
g/l
0.9
0.9
—
6
74
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
75
0.80
0.07
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
88
1.02
0.07
1.0
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
103
0.87
0.06
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
104
0.86
0.06
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
90
1.11
0.05
1.2
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
435
0.96
0.05
1.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
435
0.96
0.05
1.3
1.4
g/l
4.0
4.0
0.12
32
322
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
435
0.96
0.05
1.3
1.4
g/l
7.4
7.4
0.01
33
328
(3003740) Influenza virus B Ag [Presence] in Specimen
10
91
1.10
0.04
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
12
129
0.93
0.03
1.6
1.8
g/l
2.1
1.0
0.48
12
99
(3002523) Influenza virus A Ag [Presence] in Specimen
10
92
1.09
0.03
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
601
0.98
0.02
1.2
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
148
0.95
0.02
1.9
3.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
148
0.95
0.02
1.3
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
105
1060
0.99
0.02
2.3
3.2
ng/l
241.1
241.7
0.00
94
988
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
117
0.94
0.01
1.2
1.2
u/ml
2.0
6.4
—
5
57
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
35
342
1.02
0.01
1.4
1.5
mg/l
30.1
39.2
0.93
27
272
(3034860) Kappa light chains.free [Mass/volume] in Serum
35
342
1.02
0.01
1.4
1.5
mg/l
49.9
53.4
0.17
27
270
(3016018) Differential panel - Cerebral spinal fluid
10
94
1.06
0.01
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
106
0.94
0.01
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
93
924
1.01
0.00
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
366
1.01
0.00
1.3
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
101
0.99
0.00
1.1
1.3
—
—
—
0
0
(4306422)
12
119
1.01
0.00
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
149
1.01
0.00
1.2
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
405
0.99
0.00
1.3
1.4
g/l
3.1
3.1
0.09
32
325
(3006270) Folate [Moles/volume] in Blood
10
95
1.05
0.00
1.3
1.2
nmol/l
298.1
336.2
—
10
82
(3000034) Microalbumin [Mass/volume] in Urine
11
115
0.96
0.00
2.1
3.3
mg/l
94.8
25.0
—
5
91
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
7.2
—
0
6
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
1112.3
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
15.6
—
0
8
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
17.5
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
10.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.7
—
2.0
—
0
6
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
66
0.91
0.00
2.0
1.7
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
1.2
—
0
7
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
30.6
—
0
5
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
66
0.91
0.00
1.0
1.8
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4010399)
77
770
1.00
0.00
1.2
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
53.4
—
0
9
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(4024509)
8
83
0.96
0.00
2.5
1.6
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.4
—
0
5
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_OESOPHAGUS_EXALLC – Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).